home  versant ventures search for versant ventures on linkedin share lp access contact us careers ive built two companies with versant ventures and value their distinctive investment approach they have a clear understanding of the recipe for startup company success and represent a premium brand in healthcare venture capital today david clapper  minerva surgical versant invested in life the people at versant understand the entrepreneurial process they take a longterm view of the portfolio company and help provide perspective and support in times thick and thin amar sawhney  ocular therapeutix versant invested in life versant has been and continues to be a superb investor they provide insight and counsel to our efforts and their willingness to roll up their sleeves to problem solve with us has been invaluable michael d clayman md  flexion therapeutics versant invested in life featured case study biotechnology quanticel pharmaceuticals quanticel technology is based on the work of stanford researchers and company founders stephen quake and michael clarke versant had backed other genomic technologies invented by quake and moved quickly to incubate quanticel in  shortly after the company was founded the idea behind quanticel’s singlecell genomic analysis technology is to unlock the mystery of cancer drug resistance through the analysis of tumor cell heterogeneity as a tumor grows and cancer cells rapidly replicate the genetic diversity of these cells increases full quanticel pharmaceuticals case study news highlights venatorx pharmaceuticals raises  million series b venatorxfinal repare therapeutics raises us million series a repare therapeutics raises us million series a crispr therapeutics announces the appointment of jon terrett phd to head of immunooncology research and translation crispr appoints jon terrett versant ventures launches jecure therapeutics jecureseriesa contact us  versant ventures search for versant ventures on linkedin share lp access contact us careers contact us at one of our five offices san francisco one sansome suite  san francisco ca  phone   fax   new york  west st street suite  new york ny  phone   minneapolis  equitable drive suite  eden prairie mn  phone   basel switzerland versant ventures switzerland gmbh aeschenvorstadt  ch basel switzerland phone      canada versant ventures canada limited  great northern way suite  vancouver bc vt t phone   versant overview  versant ventures search for versant ventures on linkedin share lp access contact us careers propelling life sciences companies versant ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies the firm invests across the healthcare sector and at all stages of company development with an emphasis on the discovery and development of novel therapeutics with  billion under management and offices in north america and europe versant has built a team with deep investment operating and scientific expertise that enables a handson approach to company building since the firm’s founding in  nearly  versant companies have achieved successful acquisitions or ipos versant in europe versant ventures has a team in basel switzerland dedicated to working with entrepreneurs industry and leading academics across europe the team has decades of experience in the pharmaceutical and biotechnology industries including global roles in drug discovery research and product development for companies such as roche novartis and lilly versant’s basel office is led by tom woiwode guido magni and gianni gromo   biotechnology archives  versant ventures search for versant ventures on linkedin share lp access contact us careers biotechnology venatorx pharmaceuticals malvern pa venatorx is a developing nextgeneration antibiotics to treat multidrug resistant mdr infections vividion therapeutics san diego ca vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteomewide drug and target discovery repare therapeutics montreal canada repare is developing new precision oncology drugs for patients that target specific vulnerabilities of tumor cells northern biologics toronto canada northern biologics is developing novel therapeutic antibodies for the treatment of human diseases in oncology fibrosis and other diseases piqur therapeutics basel switzerland piqur is a swiss pharmaceutical company focusing on the discovery and development of innovative small molecule therapeutics based on lipid kinase pik and mtor inhibition for the treatment of cancer as well as other indications anokion ecublens switzerland anokion is focused on leveraging its proprietary immune tolerance technology to develop novel protein therapeutics and treatments for autoimmune diseases mosaic biomedicals barcelona spain mosaic biomedicals is a barcelonabased company that develops personalized cancer treatments with a dual mechanism of action to eliminate cancer stem cells and reactivate the tumor’s immune system mosaic’s innovative treatments are derived from a deep understanding of the tumor biology and aim to offer safer and more effective options to cancer patients aavlife paris france aavlife is a gene therapy company focused on developing treatments for rare diseases with great unmet medical need inception ibd san diego ca inception ibd is focused on translating academic discoveries in the field of ibd into firstinclass small molecule drugs crispr therapeutics basel switzerland crispr therapeutics is making use of significant advances in the field of gene editing and focused on translating the crisprcas technology in truly transformational therapeutics for common and rare genetic diseases audentes therapeutics san francisco ca audentes is a biotechnology company committed to the development and commercialization of innovative new treatments for people with serious rare diseases through the application of gene therapy technology gensight biologics tassin la demi lune  france gensight is a leading company in gene therapy specialized in prevention of loss of vision and restoration of sight inception  san diego ca inception  is focused on the discovery of therapeutics for sensorineural hearing loss  the company has entered into a partnership with roche with a prenegotiated acquisition at ind viral logic systems technology seattle wa vlst corp has developed a novel and streamlined approach to speed the development of effective therapeutics for the treatment of inflammatory and autoimmune diseases theraclone sciences seattle wa theraclone sciences inc is focused on developing novel human therapeutic antibodies for the treatment of infectious diseases acumen san francisco ca acumen is revolutionizing the diagnosis and treatment of autism and other disorders through smartphoneenabled digital behavior evaluation improving outcomes for patients and simplifying care for specialists phaserx seattle wa phaserx is developing a novel approach to intracellular delivery of macromolecules inception  san diego ca inception  is focused on oncology the company is translating biological insights into novel firstinclass small molecule drugs for cll and other oncology indications spanning both liquid and solid tumors inception  san diego ca inception  is translating biological insights into novel firstinclass small molecule drugs to treat diseases of aging ruiyi shanghai china ruiyi is a drug discovery and development company focused on firstinclass antibodies targeting g protein coupled receptors gpcrs am ventures menlo park ca am ventures is a seedstage fund focused on creating and building biotech companies portfolio companiesbiotechnology biotechnology exits  ipos medical devices medical device exits  ipos additional investments additional investment exits discovery engines case studies amira pharmaceuticals inception  inc quanticel pharmaceuticals medical devices archives  versant ventures search for versant ventures on linkedin share lp access contact us careers medical devices ebb therapeutics oakmont pa ebb is developing a therapeutic device for insomnia inari medical irvine ca inari medical is a medical device company pioneering innovative devices for the interventional treatment of vascular thrombi and emboli metavention minneapolis mn metavention is developing novel interventional therapies for type  diabetes sebacia duluth ga sebacia is developing a medical device to cure acne zyga technology minneapolis mn zyga is developing and marketing innovative minimally invasive surgical solutions to treat conditions of the spine rox medical san clemente ca rox is developing devices for treatment of diseases of the respiratory system respicardia minnetonka mn respicardia is developing an implantable system to treat central sleep apnea in patients with heart failure orametrix richardson tx orametrix is a leading industry provider of innovative d technology solutions facilitating and improving the quality of orthodontic care neurotech pharmaceuticals lincoln ri neurotech pharmaceuticals is pioneering encapsulated cell technology as a drug delivery platform for retinal degenerative diseases minerva surgical cupertino ca minerva is developing next–generation technology for treating excessive menstrual bleeding microfabrica van nuys ca microfabrica has developed a broad microscale platform for minimally invasive procedures and for complex dynamic implants intuity medical sunnyvale ca intuity medical formerly rosedale is developing a handheld all inone discrete bloodbased diagnostic platform that will enhance glucose monitoring for diabetic patients holaira plymouth mn novel devices to treat obstructive lung disease  previously innovative pulmonary solutions halscion suwanee ga halscion is advancing a solution for reduction of surgically induced scarring forsight vision  menlo park ca forsight vision is evaluating a variety of technologies to address important unmet patient needs in key ophthalmic markets forsight vision  menlo park ca forsight vision  inc is developing novel ocular drug delivery technologies ceterix orthopedics fka suturepro technologies inc menlo park ca ceterix is developing a new orthopedic suturing technology that is focused on improving easeofuse and operative speed celula san diego ca celula is developing rare cell isolation technology for diagnostic and therapeutic purposes benvenue medical santa clara ca benvenue medical is developing and marketing innovative spine repair technology alterg fremont ca alterg is marketing its “gtrainer” technology a treadmill system that reduces the users’ body weightimpact of running and thereby enhances physical rehabilitation from orthopedic or neurological injury acufocus irvine ca acufocus is developing a corneal implant to treat presbyopia the need for reading glasses portfolio companiesbiotechnology biotechnology exits  ipos medical devices medical device exits  ipos additional investments additional investment exits discovery engines case studies amira pharmaceuticals inception  inc quanticel pharmaceuticals portfolio overview  versant ventures search for versant ventures on linkedin share lp access contact us careers partnering to improve healthcare we are proud of our track record of working with extraordinary scientists entrepreneurs and business leaders to build transformational companies that impact and improve healthcare we invest our time talent leadership and expertise in all our portfolio partnerships we pursue opportunities where we can add value through our handson collaborative approach and devote the appropriate mix of strategic advice domain expertise and capital to help accelerate their growth we invest in life and in success since our inception in  we have invested in over  seed early and growth stage companies – of which  have gone public or been acquired to date business directories by state locations top states florida   businesses california   businesses texas   businesses new york   businesses pennsylvania   businesses advertisements states alabama  companies found  people found alaska  companies found  people found arizona  companies found  people found arkansas  companies found  people found california  companies found  people found colorado  companies found  people found connecticut  companies found  people found delaware  companies found  people found district of columbia  companies found  people found florida  companies found  people found georgia  companies found  people found hawaii  companies found  people found idaho  companies found  people found illinois  companies found  people found indiana  companies found  people found iowa  companies found  people found kansas  companies found  people found kentucky  companies found  people found louisiana  companies found  people found maine  companies found  people found maryland  companies found  people found massachusetts  companies found  people found michigan  companies found  people found minnesota  companies found  people found mississippi  companies found  people found missouri  companies found  people found montana  companies found  people found nebraska  companies found  people found nevada  companies found  people found new hampshire  companies found  people found new jersey  companies found  people found new mexico  companies found  people found new york  companies found  people found north carolina  companies found  people found north dakota  companies found  people found ohio  companies found  people found oklahoma  companies found  people found oregon  companies found  people found pennsylvania  companies found  people found puerto rico  companies found  people found rhode island  companies found  people found south carolina  companies found  people found south dakota  companies found  people found tennessee  companies found  people found texas  companies found  people found utah  companies found  people found vermont  companies found  people found virginia  companies found  people found washington  companies found  people found west virginia  companies found  people found wisconsin  companies found  people found wyoming  companies found  people found company directory browse directory by company name a b c d e f g h i j k l m n o p q r s t u v w x y z more people directory names starting with letters a b c d e f g h i j k l m n o p q r s t u v w x y z use the pdf button on the web page the only way to print is to view or download the pdf accessed by nilsacentenoyahoocom on   am bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version versant venture capital v lp private company information  bloomberg july    am et capital markets company overview of versant venture capital v lp snapshot people company overview versant venture capital v lp specializes in making growth capital investment in seed and early stage companies it targets the healthcare sector including life sciences devices diagnostics biotechnology and biopharma it seeks to invest in firms involved in the discovery and development of novel therapeutics the fund seeks to invest in canada one sansome streetsuite san francisco ca united states phone  fax  key executives for versant venture capital v lp mr william j link phd managing director age  mr samuel d colella mba managing director age  mr robin l praeger managing director dr bradley j bolzon md phd chairman  md age  mr kirk g nielsen managing director compensation as of fiscal year  similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact versant venture capital v lp please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close versant venture capital v lp top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active versant venture capital v lp • san francisco ca • venture capital fund how do i update this listing versant venture capital v is based out of san francisco the firm last filed a form d notice of exempt offering of securities on  the filing was for a pooled investment fund venture capital fund the notice included securities offered of pooled investment fund interests summary dg insider form  form d  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from versant venture capital v lp enter your email address below and choose submit your email cancel contact info versant venture capital v lp one sansome street san francisco ca     business phone  recent sec filings a filed on   filed on   filed on  da filed on  d filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading form d filings form d is a form to be used to file a notice of an exempt offering of securities with the securities and exchange commission form d contains basic information about the offering and the company form d filings filing date form type industry group securities offered total offering amount total amount sold total remaining  d pooled investment fund venture capital fund pooled investment fund interests    other issuers in filings name address versant affiliates fund v lp  sand hill road building  suite  menlo park ca  versant ophthalmic affiliates i lp  sand hill road building  suite  menlo park ca  related parties included in filings name address relationship bradley bolzon subscription required director charles warden subscription required director kirk nielsen subscription required director na versant ventures v llc subscription required director robin l praeger subscription required director ross jaffe subscription required director samuel colella subscription required director william link subscription required director elevate your investments try it for free today in funding builddirect versant venture capital gallop labs  betakit by douglas soltys canadian startup news funding december   today in funding builddirect versant venture capital gallop labs more big financing news in canada with a big dose of cash foreshadowing future healthcare investment here’s the latest on who raised how much from whom builddirect raises  million vancouverbased builddirect announced that it has raised  million in financing from mohr davidow ventures bdc capital difference capital financial omers ventures bmo asset management and scotia institutional asset management amongst others the company says it will use the money to rapidly expand and scale its home marketplace service designed to connect home buyers and sellers “this financing underscores the speed at which oldworld industries are breaking down and platform companies that leverage cuttingedge technology and data analytics like builddirect are putting the power in the hands of both the supply and demand side” said katherine barr general partner mohr davidow ventures “home improvement is a halftrillion dollar industry and is severely fragmented and inefficient builddirect is disrupting the existing supply chain in this industry and building a completely new highly efficient and smart system that suppliers and consumers alike will benefit from tremendously in terms of manufacturing and distribution efficiencies for suppliers and lower cost for high quality products and a much improved user experience for consumers” versant venture capital v lp closes at m versant venture captial closed its versant venture capital v lp at  million usd with significant support from canadian investors such as the business development bank of canada fonds de solidarité ftq northleaf venture catalyst fund and teralys capital the versant v lp exceeded the vc’s target size by over  million versant has indicated that the v portfolio will feature investments across the healthcare sector with a specific focus on canadian opportunities “we are witnessing significant changes in the way innovative products are developed and financed” said brad bolzon versant’s managing director “versant’s investment strategy in canada will involve more collaborative models that unite entrepreneurs investors and industry partners to advance important therapies as one of our first investments from the new fund northern biologics exemplifies this approach” gallop labs raises  million torontobased gallop labs announced an impressive  million seed round led by golden venture partners and mantella venture partners with allen lau ceo of wattpad albert lai ceo of big viking games jennifer lum founder of adelphic mobile and other angel investors participating you can read the full story here on betakit fundingtorontovancouver share on facebook twitter pinterest google  linkedin douglas soltys douglas soltys is the editorinchief of betakit and founder of betakit incorporated he has worked for a few failed companies and written about many more he spends too much time on the internet website twitter sign up for the betakit newsletter email address first name last name   required field powered by mailchimp latest posts marie chevrier’s advice to young entrepreneurs go for it betakiton victory square announces new venture arm dedicated to personalized healthtech ask an investor what are some tips for equity crowdfunding newfoundland and labrador replaces research  development corporation with innovatenl more betakit stories social data provider gnip debuts partner program to get companies plugged in to gnip today boulder cobased social media data provider gnip announced the launch of its plugged in to gnip partner program which gives partner companies access… versant ventures closes  mln for fifth fund  pe hub subscribe to pe hub wire join over  of your peers get the mustread email for pevc professionals delivered to your inbox daily — for free us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions subscribe yes no registersign in a community for professionals in private capital versant ventures closes  mln for fifth fund december   by iris dorbian print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub versant ventures closes  mln for fifth fund versant ventures has raised  million for its fifth venture fund beating its initial  million target the pool will focus on healthcare firms in all stages of development continue reading on pe hub writes versant ventures has raised  million for its fifth venture fund beating its initial  million target the pool will focus on healthcare firms in all stages of development press release san francisco – december   – versant ventures a global healthcare investment firm today announced the close of versant venture capital v lp at  million and in excess of the initial fund target of  million since its inception versant has raised  billion to invest in innovative biopharmaceutical medical device and healthcare serviceshcit companies the firm invests from offices in north america and europe and it has assembled a team with deep investment operating and scientific expertise that enables a handson approach to company building the versant v portfolio will be diversified with investments made across the healthcare sector and at all stages of company development consistent with recent strategy a primary focus will be the discovery and development of novel therapeutics many of these companies will be launched by versant and will enter into “buildtobuy” structured acquisitions with strategic partners at the outset key to that strategy are the firm’s company creation engines inception sciences and blueline bioscience which in recent years have collectively spawned seven companies and executed almost as many strategic partnerships the remainder of the fund will be devoted to high potential companies in other healthcare sectors that are in need of growth capital to develop or commercialize their products investments out of versant v began earlier this year and a number of commitments have already been made including to northern biologics a company launched by blueline bioscience that will develop novel therapeutic antibodies in a strategic partnership with celgene “we are grateful for the support of our limited partners who allow us to pursue our mission of helping exceptional entrepreneurs build the next generation of great healthcare companies” said brad bolzon managing director “it’s an exciting time to be launching versant v and we look forward to working with talented teams coinvestors and industry partners to advance important therapies and technologies that have the potential to substantially impact the industry” about versant ventures versant ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies the firm invests across the healthcare sector and at all stages of company development with an emphasis on the discovery and development of novel therapeutics with  billion under management and offices in north america and europe versant has built a team with deep investment operating and scientific expertise that enables a handson approach to company building since the firm’s founding in  nearly  versant companies have achieved successful acquisitions or ipos for more information please visit wwwversantventurescom print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub versant ventures closes  mln for fifth fund versant ventures has raised  million for its fifth venture fund beating its initial  million target the pool will focus on healthcare firms in all stages of development continue reading on pe hub writes dont miss out meet new and diverse managers in private equity venture capital and real estate at the third emerging manager connect east at new york citys harvard club click here for details sign up to our newsletter receive updates from our pe hub wire and top stories of the week newsletters first name last name email address us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions you are now subscribed to the pehub wire and top stories of the week newsletters buyouts insiderargosy group llc produces several free newsletters that are sent directly to the email you provide at registration namely pe hub wire pe hub canada wire pe hub wire top story of the week buyouts daily and vcj alert to enable us to keep providing these services free of charge we reserve the right to contact you with special invitations to sample or purchase private equityrelated products by submitting this free subscription request for any of these products you are also consenting to this communication should you ever wish to unsubscribe from a particular communication you may activate the unsubscribe mechanism at the bottom of the email this will discontinue both the special invitations mentioned previously as well as your subscription to the weekly newsletter the information you provide will be safeguarded by argosy group llcbuyouts insider the company’s subsidiaries may use it to keep you informed of relevant products and services we occasionally allow reputable companies outside of the company to mail details of products which may be of interest to you as an international group we may transfer your data on a global basis for the purposes indicated above we will never share your email or contact details with any outside company however should you have any questions please do not hesitate to contact us email protected top posts kkr to buy nature’s bounty from carlyle by luisa beltran blackrock leads funding round for fintech platform icapital by iris dorbian platinum equity to buy united site services by luisa beltran the pe hub podcast episode two by staff report private equity jobs of the week priceline kpmg novaquest are hiring by eamon murphy raymond james expands team with new hire by iris dorbian the carveout curveball by pehublogger network private equity jobs of the week cambridge associates bank of america ubs are hiring by eamon murphy microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft versant venture capital v final closes at m  cvca news versant venture capital v final closes at m  cvca news home deals  private equity growth capital portfolio secondary alternative debt financing exits  private equity venture capital other funds  private equity venture capital vc ma ipo  vc investments angel vcbacked mas ipos mas rtos others people  private equity venture capital lp portfolio advisors pe vc lp news  pe news vc news lp news portfolio news other versant venture capital v final closes at m december    print this article share it with friends versant ventures has closed versant venture capital v lp at us  million exceeding its target size of  million with significant support from bdc capital fonds de solidarité ftq northleaf venture catalyst fund and teralys capital “we are grateful for the support of all our limited partners who allow us to pursue the mission of helping exceptional entrepreneurs build the next generation of healthcare companies” said brad bolzon versant’s managing director “we are encouraged to see such strong support from canadian investors who understand the value of supporting medical innovation occurring in institutions across the country” the versant v portfolio will be diversified with investments made across the healthcare sector and at all stages of company development consistent with versant’s recent strategy a key focus will be the discovery and development of novel therapeutics this includes designing and building companies based on breakthrough discoveries and financing them with venture syndicates or pharmaceutical partners including “buildtobuy” collaborations many of these investments will be driven by versant’s own company creation engines which have collectively spawned seven new companies and consummated almost as many strategic pharmaceutical partnerships the remainder of the fund will be devoted to highpotential companies across the healthcare sector that are in need of growth capital to develop or commercialize their products “we are witnessing significant changes in the way innovative products are developed and financed” noted bolzon “versant’s investment strategy in canada will involve more collaborative models that unite entrepreneurs investors and industry partners to advance important therapies as one of our first investments from the new fund northern biologics exemplifies this approach” the new fund also gives versant the ability to continue to act as a catalyst in the resurgence of the venture ecosystem across canada “we entered canada with the idea that we could identify untapped healthcare investment opportunities” said versant partner jerel davis who oversees canadian investment activities since its inception in  versant has raised  billion to invest in innovative biopharmaceutical medical device and healthcare serviceshcit companies the firm invests from offices in the united states canada and europe tags bdc capitalfonds de solidariténorthleaf venture catalyst fundteralys capitalversant ventures share share tweet share related articles scroll back to top guestlogix closes m credit agreement information venture partner closes second fund at m investeco nets investment for second sustainable food fund from cooperators sign up for daily deals and news update industry news ottawas tech vc push bears fruit as million kensington fund closes  globe and mail instaragf infrastructure fund gets off the ground  globe and mail venture capital climbs to year high as technology booms  globe and mail cheap oil hits clean tech venture capital activity  bnn report canadian vc investment reaches  billion in  vc exit values reach record highs  betakit the top  canadian vc deals of   globe and mail cvca events cvca on twitter tweets by cvcacanada  canadian venture capital  private equity association developed by summerhilldesigncom loading close window loading please wait this may take a second or two versant ventures closes  million healthcare fund versant ventures closes  million healthcare fund dec    et from versant ventures venture capital firm to catalyze healthcare investment activities across the country with significant support from leading canadian investors vancouver dec   cnw  versant ventures a global healthcare investment firm today announced the close of versant venture capital v lp at  million us exceeding its target size of  million and including significant support from business development bank of canada fonds de solidarité ftq northleaf venture catalyst fund and teralys capital we are grateful for the support of all our limited partners who allow us to pursue the mission of helping exceptional entrepreneurs build the next generation of healthcare companies said brad bolzon versants managing director we are encouraged to see such strong support from canadian investors who understand the value of supporting medical innovation occurring in institutions across the country the versant v portfolio will be diversified with investments made across the healthcare sector and at all stages of company development consistent with versants recent strategy a key focus will be the discovery and development of novel therapeutics this includes designing and building companies based on breakthrough discoveries and financing them with venture syndicates or pharmaceutical partners including buildtobuy collaborations many of these investments will be driven by versants own company creation engines which have collectively spawned seven new companies and consummated almost as many strategic pharmaceutical partnerships examples include quanticel inception  and northern biologics a torontobased company launched today from the blueline bioscience engine that will develop novel therapeutic antibodies in a strategic partnership with celgene the remainder of the fund will be devoted to highpotential companies across the healthcare sector that are in need of growth capital to develop or commercialize their products  we are witnessing significant changes in the way innovative products are developed and financed noted bolzon versants investment strategy in canada will involve more collaborative models that unite entrepreneurs investors and industry partners to advance important therapies as one of our first investments from the new fund northern biologics exemplifies this approachthe new fund also gives versant the ability to continue to act as a catalyst in the resurgence of the venture ecosystem across canada we entered canada with the idea that we could identify untapped healthcare investment opportunities says versant partner jerel davis who oversees canadian investment activities over the last  months versant has launched multiple enterprises throughout canada including inception sciences research sites in vancouver and montreal and formed blueline bioscience a biotechnology incubator in toronto versant will take a pancanadian outlook to identify breakthroughs from world class research centers capitalize on available life sciences talent and deploy its unique investment model our vision is already becoming a reality based on the companies we have seen launch in vancouver montreal and toronto we believe that this approach to incubating and supporting early stage companies fits the canadian environment extremely well noted davis since its inception versant has raised  billion us to invest in innovative biopharmaceutical medical device and healthcare serviceshcit companies the firm invests from offices in the united states canada and europe and it has assembled a team with deep investment operational and scientific expertise that enables a handson approach to company buildingabout versant ventures versant ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies  the firm invests across the healthcare sector and at all stages of company development with an emphasis on the discovery and development of novel therapeutics  with  billion under management and offices in north america and europe versant has built a team with deep investment operating and scientific expertise that enables a handson approach to company building  since the firms founding in  nearly  versant companies have achieved successful acquisitions or ipos  for more information please visit wwwversantventurescom source versant ventures view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more dec    et preview northern biologics to develop antibody therapeutics in toronto nov    et preview versant ventures closes  million fund my news release contains wide tables view fullscreen looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search